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Abstract One of the outstanding questions in behavioral
disorders is untangling the complex relationship between
nurture and nature. Although epidemiological data
provide evidence that there is an interaction between
genetics (nature) and the social and physical environ-
ments (nurture) in a spectrum of behavioral disorders, the
main open question remains the mechanism. Emerging
data support the hypothesis that DNA methylation, a
covalent modification of the DNA molecule that is a
component of its chemical structure, serves as an
interface between the dynamic environment and the
fixed genome. We propose that modulation of DNA
methylation in response to environmental cues early in
life serves as a mechanism of life-long genome adapta-
tion. Under certain contexts, this adaptation can turn
maladaptive resulting in behavioral disorders. This
hypothesis has important implications on understanding,
predicting, preventing, and treating behavioral disorders
including autism that will be discussed.
Keywords DNA methylation.Epigenetics.Development.
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Introduction
There has been a genocentric focus in our approach to human
disease and specifically behavioral disorders such as autism in
the last century. This has been driven by the highheritability of
several common disorders such as autism. The underlying
hypothesis has beenthat differences in genesequence between
individuals could result in alteration in genome function that
would create phenotypic differences that manifest themselves
in mental or physical disorders. A tremendous effort has been
invested in genome-wide association studies of complex
disease. This endeavor has resulted in delineation of an
increasing list of associations between rare as well as common
genetic variants and behavioral disorders such as autism.
Several of these genes were also found to play an important
role in the development of the nervous system and taught us
important lessons on possible mechanisms of brain function
(Grice and Buxbaum 2006; Kumar and Christian 2009; Levitt
and Campbell 2009). It is believed that with the expansion in
whole-genome technologies and by including copy number
variations in addition to single-nucleotide polymorphisms in
genomic studies, it will be possible to strengthen and broaden
these associations (Weiss 2009; Weiss et al. 2009;A n n e ye t
al. 2010; Pinto et al. 2010). However, epidemiological data
suggest an environmental component in most behavioral
disorders including autism.
The DNA molecule bears two layers of information: the
genetic information encoded in the sequence of bases in
DNA and the pattern of distribution of methyl cytosines
(Razin and Riggs 1980; Razin and Szyf 1984)a n d
hydroxy-methyl cytosines (Kriaucionis and Heintz 2009).
The methyl groups are added to the DNA molecule after
replication by machinery that is distinct from the machinery
that replicates the DNA sequence creating within the hard
M. Szyf
Department of Pharmacology and Therapeutics,
McGill University,
Montreal, QC H3G 1Y6, Canada
M. Szyf (*)
Sackler Program for Epigenetics and Psychobiology,
McGill University,
Montreal, QC H3G 1Y6, Canada
e-mail: moshe.szyf@mcgill.ca
J Neurodevelop Disord (2011) 3:238–249
DOI 10.1007/s11689-011-9079-2chemistry of the DNA molecule itself a potential for
differential information. It has been known for several
decades that the pattern of distribution of methyl cytosines
is not equal in all tissues in a multicellular organism and
that it exhibits tissue specificity (Razin and Szyf 1984).
Thus, the DNA molecule has two identities: the ancestral
identity encoded in the sequence and the cell-specific
identity encoded in the pattern of DNA methylation. It
has been almost an established dogma that DNA methyl-
ation patterns form during embryogenesis by innate
organized developmental programs and that DNA methyl-
ation is mainly involved in cellular differentiation. It was
therefore believed that DNA methylation patterns once
formed remained fixed since cellular differentiation was
believed to be terminal. Recent data suggest however that
DNA methylation is more attentive to information from the
environment including the social environment particularly
early in life (Szyf et al. 2007). It is proposed here that the
DNA methylation pattern bears not just the tissue-specific
identity but also the individual identity formed as a
response to interactions with the environment early in life
and throughout life. The pattern of DNA methylation is
proposed to play an important role in social adaptation of
genome function and therefore in behavioral phenotypes.
We will discuss the possible implications of this hypothesis
on prediction, prevention, and treatment of neurodevelop-
mental behavioral disorders.
DNA methylation patterns
Vertebrate DNA is covalently modified by enzymatic
addition of a methyl group to cytosines in DNA. The
hallmark of DNA methylation in vertebrates and many
other organisms is the fact that the distribution of the
methyl groups in the DNA varies across different cell
types in an organism. This creates a cell-type-specific
pattern of DNA methylation. In vertebrates, the CG
dinucleotide sequence is a principal target of DNA
methylation (Gruenbaum et al. 1981) since it is preferen-
tially recognized by vertebrate DNA methyltransferases
(Gruenbaum et al. 1982). CG is the only dinucleotide
sequence that contains a cytosine that is a palindrome and
could be copied during cell division by a semiconservative
DNA methyltransferase from the parental strand onto the
daughter strand (Razin and Riggs 1980). Heritability of
DNA methylation mark is critical for its role as an
epigenetic signal that bears the specific cellular identity.
This concept of automatic heritability was behind the
prevailing dogma that once the innate programmed
developmental processes form DNA methylation patterns
during embryogenesis they remain fixed after birth to
maintain cellular identity. Recent studies suggest that
DNA methyation could occur in non-CG sequences at
least in stem cells but it is unclear how prevalent non-CG
methylation is in the brain (Lister et al. 2009;F u s oe ta l .
2010). In any case, the presence of non-CG methylated
sites in our genomes suggests that mechanisms for
inheritance of DNA methylation exist that are not defined
automatically by the DNA methylation of the parental
template strand of DNA. For example, when a new CC
site is generated during DNA replication the complemen-
tary site on the parental strand of DNA is GG and it
obviously cannot guide the methylation of the CC on the
new strand of DNA. This has important implications on
our understanding of the scope of biological functions that
DNA methylation is involved in as will be discussed
below (Szyf 2010). Many of the current assays of DNA
methylation are biased to CG methylation. We might have
missed important DNA methylation responses that involve
non-CG methylation. For example, Fuso et al. 2010 have
recently shown that during muscle differentiation, DNA
demethylation of a regulatory region of the myogenin
gene occurs mainly in methylated rich but CG poor
sequence (Fuso et al. 2010). The possibility that DNA
methylation could occur outside CG islands forces us to
revisit this especially in the brain however it is as yet
unclear whether non-CG methylation plays a role in
postmitotic neurons.
Differential DNA methylation is an excellent candi-
date to serve as the “epigenetic” mechanism predicted by
Waddington as an explanation for how one genome
expresses multiple phenotypes in a multicellular organ-
ism (Waddington 1959; Razin and Riggs 1980). Since
cellular phenotypes once generated during embryogenesis
are extremely stable, this requires that DNA differential
methylation patterns once generated would be inherited
faithfully and accurately. Several lines of evidence
supported this hypothesis. Cell-specific DNA methylation
patterns were described almost two decades ago (Razin
and Szyf 1984; Benvenisty et al. 1985) and were recently
confirmed by whole-genome methylome mapping (Lister
et al. 2009). Also, the prediction that a semiconservative
enzyme copies the methyl groups from the palindromic
CG on the template strand to the complementary CG on
the daughter strand (Razin and Riggs 1980)w a sc o n -
firmed as well; providing a mechanism for faithful
maintenance of the DNA methylation pattern in diverse
cell lineages (Gruenbaum et al. 1982).
The involvement of DNA methylation in cellular
differentiation and in the “canalization” leading to terminal
differentiation might imply that the DNA methylation
pattern in differentiated cells is also terminal. However,
there is considerable epidemiological data suggesting that
experience after birth has a profound effect on the
phenotype later in life. How could a static and relatively
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This question is especially pertinent in the nervous system
where nurture after birth plays an important role in brain
development. One of the important new concepts in DNA
methylation has been the idea that DNA methylation might
be diversifying genome function not only in response to
innate developmental programs but also in response to
environmental exposures enabling the same genome to
express different phenotypes (Szyf 2009b). DNA methyla-
tion is therefore proposed to be a general mechanism of
genome adaptation in addition to its role in conferring cell
type identity to genomes during differentiation.
Differential DNA methylation is a strong candidate to
regulate differential gene expression. There is an overall
inverse correlation between DNA methylation in several
regulatory regions of genes and gene expression which was
discovered in the early eighties (Razin and Szyf 1984)( R a z i n
and Riggs 1980) and was confirmed by whole-genome
approaches (Rauch et al. 2009). However, exceptions to this
rule exist and unmethylated promoters of genes that are
silenced are frequent in the genome. It is possible that
methylation dependent regulatory regions that were not
examined in the published studies control these genes.
Alternatively, it is important to note that DNA methylation
and gene expression studies describe different levels of gene
expression regulation. DNA methylation patterns program
gene expression potential and condition genes to respond to
appropriate environmental and physiological signals whereas
expression studies reveal a transient state of expression.
One of the early landmark discoveries in the field was
the inverse correlation between active chromatin configu-
ration and DNA methylation. Highly methylated DNA
regions are packaged in the nucleus in inactive chromatin
configuration (Razin and Cedar 1977). This data points to a
relationship between two critical elements of the epige-
nome: chromatin modification and DNA methylation.
Several studies support a bilateral relationship between
DNA methylation and chromatin structure; DNA methyla-
tion directs the formation of inactive chromatin while
inactive chromatin targets DNA methylation. The converse
is also true; loss of methylation targets activating histone
modification marks and active histone methylation marks
such as histone acetylation facilitate DNA demethylation
(D’Alessio and Szyf 2006).
Regulation of promoter activity by DNA methylation
Although global changes in DNA methylation that cover
wide regions of the genome occur in pathological
conditions such as cancer (Feinberg and Vogelstein
1983) and lupus (Cornacchia et al. 1988; Yung and
Richardson 1994), the most established role of DNA
methylation is in regulation of promoter activity and gene
regulatory regions (Stein et al. 1982). These account for a
minor fraction of the changes in DNA methylation
documented in literature. At least two mechanisms were
demonstrated for inhibition of gene activity by DNA
methylation. A methyl group positioned in a recognition
element for a transcriptional factor can block binding of
the transcription factor to the promoter (Comb and
Goodman 1990; Inamdar et al. 1991). Alternatively,
methylated DNA attracts methylated DNA binding pro-
teins such as the Rett syndrome protein methyl-CpG
binding protein 2 (MeCP2), which in turn recruit histone
modification enzymes such as histone deacetylases
(HDAC)s to the gene precipitating an inactive gene-
silencing chromatin configuration (Nan et al. 1997).
Although the main focus of most studies has been on
promoter DNA methylation, recent whole-genome meth-
ylation analyses revealed an interesting positive relation-
ship between DNA methylation in bodies of genes and
gene expression (Hellman and Chess 2007; Lister et al.
2009; Rauch et al. 2009). A revealing example is X
inactivation in females; although promoters in the active X
are unmethylated relative to the inactive X the reverse is
true for the bodies of genes which are hypermethylated on
the active X (Hellman and Chess 2007). A large fraction
of the methylation in DNA however occurs in inter-genic
regions and in repetitive sequences, and this methylation
might play yet unknown roles. Methylation of retroviral
elements in the genome was proposed to silence ectopic
expression from these parasitic elements that could disrupt
normal genome function (Yoder et al. 1997).
DNA methylation enzymes
To understand how DNA methylation patterns are
formed it is important to decipher the machinery that
lays down the DNA methylation pattern as well as the
machinery responsible for its maintenance (see Fig. 1 for
review of DNA methylation reactions). Since brain
maturation doesn’t stop at birth and is responsive not
only to innate signals (nature) but also to the environment
(nurture) it is critical to determine whether the DNA
methylation pattern is fixed at birth as had been the
accepted dogma or whether it continues to change during
early life. A related question is whether the DNA
methylation machinery is responsive to environmental
signals specifically the social environment, or whether it is
solely defined by an innate program. If indeed environ-
mental signals could affect DNA methylation patterns, this
could set life-long gene expression programs that could
result in behavioral pathologies such as autism spectrum
disorders.
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The DNA methylation reaction is catalyzed by DNA
methyltransferase(s) (DNMT) (Razin and Cedar 1977).
Methylation of DNA occurs immediately after replication
by a transfer of a methyl moiety from the donor S-adenosyl-
L-methionine (SAM, AdoMet) in a reaction catalyzed by
DNMT (Turnbull and Adams 1976). Three distinct phylo-
genic DNA methyltransferases were identified in mammals.
DNMT1 shows preference for hemimethylated DNA in
vitro, which is consistent with its role as a maintenance
DNMT, whereas DNMT3A and DNMT3B methylate unme-
thylated and methylated DNA at an equal rate which is
consistent with a de novo DNMT role (Okano et al. 1998)
(Fig. 1). Two additional DNMT homologs were found;
DNMT2, whose substrate and DNA methylation activity is
unclear (Vilain et al. 1998) but was shown to methylate
tRNA (Goll et al. 2006; Rai et al. 2007) and DNMT3L
which is essential for the establishment of maternal genomic
imprints but lacks key methyltransferase motifs, and is
possibly a regulator of methylation rather than an enzyme
that methylates DNA (Bourc’his et al. 2001;B o u r c ’his and
Bestor 2004). Knockout mouse data indicate that DNMT1 is
responsible for a majority of DNA methylation marks in the
mouse genome (Li et al. 1992) as well as the human genome
(Chen et al. 2007), whereas DNMT3A and DNMT3B are
responsible for some but not all de novo methylation during
development (Okano et al. 1999).
Razin and Riggs proposed that the DNA methylation
pattern was accurately and automatically inherited during
replication since maintenance DNMT could only methylate
hemimethylated sites generated on the nascent DNA strand
during replication of a methylated CG dinucleotide in the
template strand (Fig. 1). DNA methylation was therefore
proposed to be truly heritable by an automatic semiconser-
vative mechanism (Razin and Riggs 1980).
It is becoming clear now, however, that DNMTs are
targeted to specific sequences and that the targeting factors
are required not only for generating the patterns of
methylation but also for maintaining the pattern of DNA
methylation. For example, ubiquitin-like, containing PHD
and RING finger domains 1, also known as NP95 in mouse
and ICBP90 in human is required for targeting DNMT1 to
newly replicating hemimethylated DNA, (Bostick et al.
2007). DNMTs are found in complexes with other proteins
that include other chromatin modifying proteins such as
HDAC1 and HDAC2 (Fuks et al. 2000, 2001). The
discovery that DNMT1 and other DNMTs are targeted to
specific sites by chromatin modifying enzymes suggests
that DNA methylation is not exclusively automatic and
provides a mechanism for a targeted change in DNA
methylation in response to activation of signaling pathways
DNA demethylases
For DNA methylation to act as a responsive signal after
birth in nondividing neurons, it needs to be reversible in
postmitotic cells like other biological signals (Ramchandani
et al. 1999). It was originally believed that demethylation
could occur only through a “passive” process of replication
in absence of DNMT1 (Fig. 1). The most controversial
issue in the DNA methylation field is the question of
whether the DNA methylation reaction is reversible
(Ramchandani et al. 1999). Several authors have provided
evidence for replication-independent demethylation (Wilks
et al. 1984;S z y fe ta l .1995; Oswald et al. 2000; Lucarelli
et al. 2001; Bruniquel and Schwartz 2003), and it has been
shown that brain extracts are capable of demethylating
“naked” DNA substrate in vitro (Mastronardi et al. 2007;
Dong et al. 2008). The strongest evidence for dynamic
methylation–demethylation comes from several studies
showing active demethylation in postmitotic neurons
(Weaver et al. 2004; Levenson et al. 2006; Miller and
Sweatt 2007; Feng et al. 2010). Conditional knockout of
DNMT1 in postmitotic neurons results in DNA demethy-
lation suggesting the presence of demethylase activity in
nondividing neurons (Feng et al. 2010).
T h em a i no p e nq u e s t i o ni sw h a ti st h em e c h a n i s mo f
DNA demethylation (see Fig. 2 f o rr e v i e wo fD N A
demethylation reactions). The most widely accepted
mechanisms for active DNA demethylation involve DNA
repair and replacement of the methylated cytosine nucle-
otide by an unmethylated cytosine nucleotide by either
CH3
DNA replication
De novo methyltransferase
Demethylase
CH3
CH3 CH
(DNMT3a, 3b and DNMT1?)
(DNMT1)
CH3
CH3
CH3
CH3
CH3
CH3
CH3 CH3 CH3 CH3
CH3 CH3
CH3
CH3
CH3
CH3
DNA replication
CH3
CH3
passive 
demethylation
Fig. 1 DNA methylation reactions. DNA methyltransferases transfer
methyl groups (CH3) from the methyl donor S-adenosyl-L-methionine to
cytosines in DNA. Two kinds of DNA methylation reactions are shown;
de novo methyltransferases (DNMT3a and DNMT3b) add new methyl
groups to cytosines in DNA, maintenance DNA methyltransferase
(DNMT1) copies the DNA methylation pattern from the template strand
following DNA replication. Passive demethylation: if DNMT1 is absent
during DNA replication, the DNA will be copied without being
methylated and will be thus “passively” demethylated. DNA could be
actively demethylated by demethylases that remove the methyl groups
from DNA in the absence of DNA replication (see Fig. 2)
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nism is removal of the methylated cytosine by a
glycosylase activity; the abasic site is then repaired and
replaced with an unmethylated cytosine (Razin et al. 1986;
Jost 1993). A study proposed that DNMTs participate in
demethylation by deamination of the methyl cytosine to
thymidine creating a C/T mismatch, which is then
corrected by a mismatch-repair mechanism (Kangaspeska
et al. 2008). DNMTs were previously shown to deaminate
5-methylcytosines (Shen et al. 1992; Zingg et al. 1998)
under conditions of low SAM. Growth arrest and DNA-
damage-inducible, alpha (GADD45A), a DNA repair
protein was proposed to participate in catalysis of active
DNA demethylation by an unknown DNA repair-based
mechanism (Barreto et al. 2007). However, this was
disputed (Jin et al. 2008). A very recent study suggested
that demethylation in zebra fish embryos involves a
complex sequence of coupled enzymatic reactions;
activation-induced cytidine deaminase (AID; which con-
verts 5-meC to thymine), a G/T mismatch-specific
thymine glycosylase methyl-CpG binding domain protein
4 and repair promoted by GADD45A (Rai et al. 2008).
AID has been implicated in the global demethylation in
mouse primordial germ cells as well (Popp et al. 2010).
In contrast to these repair-based mechanisms, we have
previously proposed that demethylation is truly a
reversible reaction that involves removal of the methyl
moiety rather than breaking the DNA and fixing it with
an unmethylated cytosine (Ramchandani et al. 1999). We
proposed that the methylated DNA binding protein
(MBD2) was a bona fide demethylase that removed
methyl groups from DNA and truly reversed the DNA
methylation reaction. This is to date the only described
bona fide demethylase. MBD2 has been implicated in the
activation of both methylated and unmethylated genes
(Fujita et al. 2003; Angrisano et al. 2006). Several groups
(Ng et al. 1999;W a d ee ta l .1999) have contested the
demethylase and transcriptional activating properties of
MBD2. Studies by Detich et al. have demonstrated MBD2
demethylase activity in vitro (Detich et al. 2002). Hamm
et al. (Hamm et al. 2008)h a v ep r o p o s e da no x i d a t i v e
mechanism of 5-cytosine DNA demethylation by MBD2.
According to this mechanism, oxidation of the methyl
moiety generates 5-hydroxymethylcytosine by oxidation,
which is followed by release of the methyl residue in
formaldehyde. Interestingly, 5-hydroxymethylcytosine
was recently discovered in mammalian DNA (Pelizzola
et al. 2008). A recent study has shown that TET1, an
enzyme that converts methylcytosine to hydroxymethyl-
cytosine, is required for maintaining the demethylated
state of nanog in mouse ES cells supporting a possible
role for TET1 and 5-hydroxymethylcysoine as an inter-
mediary in the demethylation reaction (Ito et al. 2010). In
summary, although there is no agreement as of yet on the
mechanism of DNA demethylation, the presence of active
demethylation in somatic cells is widely acknowledged.
DNA methylation as a genome adaptation mechanism
and as a source of mental health disorders
Our new understanding of the DNA methylation and
demethylating enzymes sets the stage for a life-long role
for DNA methylation in modulation and fine tuning of
DNA methylation patterns. It is also consistent with the
idea that DNA methylation could be responsive to
environmental signals and allow the genome to adapt its
programs to signals from the social environment. It is
interesting to note that there is evolutionary evidence for
involvement of DNA methylation in sociality especially in
the caste structure in the honeybee (Kucharski et al. 2008;
Maleszka 2008; Lyko et al. 2010). It is possible that DNA
methylation evolved to translate social information to
genomic programs of social behavior, which is especially
pertinent for autism. Epidemiological data points to the
importance of early-life experience in setting life-long
health and mental health trajectories in humans (Power et
al. 2006). It is therefore hypothesized that early life is an
especially sensitive time for DNA methylation adaptation in
the brain and system wide. It is proposed that a DNA
methylation genome-wide adaptation can turn “maladap-
tive” under specific contexts later in life and result in
Glycosylase (MBD4, 5-MCDG)
Deamination (AID, DNMTs)
Repair (GADD45)
Hydroxylation
(TET1)
Fig. 2 Mechanisms of active DNA demethylation. Several demethyla-
tion reactions were suggested. Direct demethylation by a demethylase
enzyme(dMTase; MBD2 is a putative candidate) could release a methyl
moiety (CH3) in the form of either methanol or formaldehyde.
Alternatively, the methyl cytosine ring could be modified by either
deamination catalyzed for example by AID or by the DNA methyl-
transferases (DNMT) which were shown to catalyze deamination of 5-
methylcytidine in the absence of SAM or hydroxylation of the methyl
moiety catalyzed by TET1. The modified base is then excised and
repaired. Alternatively, the bond between the sugar and the base is
cleaved (by glycosylases such as MBD4 or 5-methylcytosine glyco-
sylase 5-MCDG) followed by repair. Repair proteins shown to be
associated with demethylation were GADD45(a and b)
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mechanism leading to pathology will involve several gene
circuits and a system-wide adaptation of the DNA
methylation pattern to an anticipated environment. This is
consistent with the complex gene expression manifestation
of many mental health disorders including autism. This
mechanism suggests that mental health disabilities would
emerge as a consequence of an organized fine tuning of
DNA methylation patterns that is a response for cues
coming from the early-life social environment. However,
this hypothesis remains to be tested as it is unknown
whether large changes in DNA methylation occur in the
brains of individuals with autism.
An alternative mechanism is that stochastic DNA
methylation errors in the germ line similar to single-
nucleotide polymorphisms or DNA methylation errors
limited to certain tissues would result in disruption of gene
function leading to mental health pathology. The existence
of stochastic differences in DNA methylation in the germ
line and existence of such differences in DNA methylation
even between identical twins were recently demonstrated
(Kaminsky et al. 2006; Petronis 2006; Mill et al. 2008;
Kaminsky et al. 2009; Flanagan et al. 2006). There are
fundamental differences in the possible implications of an
adaptive versus a stochastic mechanism of emergence of
DNA methylation differences on prevention, prediction and
treatment of behavioral pathologies. We will present several
lines of evidence suggesting that the early social environ-
ment plays an active role in adaptations of the DNA
methylation pattern in the brain and the immune system.
Epigenetic programming by maternal care in rodents
There are several models that measure the impact of early-
life social environment on behavior and other health
phenotypes later in life. Animal models could be used to
test whether the impact of early-life social environment on
the phenotype is mediated by “genetic” or “epigenetic”
mechanisms. Maternal behavior plays a cardinal role in the
behavioral development of mammals. Models of maternal
deprivation in primates and rodents and natural variation in
maternal care in rodents were used to demonstrate the
profound impact of maternal care and “nurture” on a panel
of phenotypes in the offspring that last into adulthood
(Ruppenthal et al. 1976; Suomi et al. 1976).
Hippocampal Glucocorticoid receptor (GR) controls
the negative feedback of the HPA axis by glucocorti-
coids. In the rat, the adult offspring of mothers that
exhibit increased levels of pup licking/grooming (i.e.,
High LG mothers) over the first week of life show
increased hippocampal (GR) expression, enhanced glu-
cocorticoid feedback sensitivity, decreased hypothalamic
corticotrophin releasing factor (CRF) expression and
more modest HPA stress responses compared to animals
reared by Low LG mothers (Liu et al. 1997; Francis et al.
1999). The GR/NR3C1 gene encoding the glucocorticoid
receptor (GR exon 17 promoter) exhibits differences in
DNA methylation and histone acetylation in the hippo-
campus of the offspring of high and low LG mothers.
Differences in epigenetic programming in response to
differences in maternal LG emerged early in life and
remained stable into adulthood illustrating how epigenetic
programming early in life could set up life-long behavioral
trajectories (Weaver et al. 2004).
The basic concepts of this study were repeated more
recently in several other models of early-life social
adversity. Exposure of infant rats to stressed caretakers that
displayed abusive behavior produced persisting changes in
methylation of BDNF gene promoter in the adult prefrontal
cortex (Roth et al. 2009). Early-life stress in mice caused
sustained DNA hypomethylation of an important regulatory
region of the arginine vasopressin (AVP) gene (Murgatroyd
et al. 2009).
Evidence for DNA methylation variation associated
with early-life adversity in humans
An extremely important question is whether the results in
rodents could be translated to humans? The state of
methylation of ribosomal RNA (rRNA) gene promoters
and GR were examined a cohort of suicide victims in
Quebec who were abused as children and their control
group. rRNA forms the skeleton of the ribosome, the
protein synthesis machinery. Protein synthesis is essential
for building new memories and creating new synapses in
the brain. Our genome contains around 400 copies of the
genes encoding rRNA. One possible way to control the
protein synthesis capacity of a cell is through changing the
fraction of active rRNA alleles in a cell (Brown and Szyf
2007). We have previously shown that the fraction of rRNA
genes that is active and is associated with the RNA Pol1
transcription machinery is unmethylated while the fraction
that is inactive is methylated (Brown and Szyf 2007). Our
results showed that the suicide victims who experienced
childhood abuse had higher overall methylation in their
rRNA genes and expressed less rRNA. This difference in
methylation was region specific: it was present in the
hippocampus and was not observed in the cerebellum.
Moreover, although significant methylation differences
were observed between the controls and the suicide victims,
no sequence differences were observed. The fact that the
difference in methylation was brain-region specific and that
no sequence differences were observed further strengthens
the conclusion that this difference in methylation was
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(McGowan et al. 2008). These data point to the possibility
that the effects of early-life adversity might not be limited
to the usual suspects of highly brain-specific genes but that
ubiquitously expressed genes could be involved as well.
Modulation of expression of ubiquitous genes might be
important in modulating brain function.
Individuals with treatment-resistant forms of major
depression show decreased GR expression and increased
HPA activity. Site-specific differences in DNA methylation
in the GR exon 1f promoter between suicide completers
who had reported social adversity early in life and suicide
completers who did not experience social adversity early in
life were detected in this study. These differences in DNA
methylation were associated with reduced expression of the
GR gene (McGowan et al. 2009). Differences in DNA
methylation of the GR promoter promoter were observed
also in peripheral blood cells; the GR promoter was more
methylated in lymphocytes in newborns exposed prenatally
to maternal depression than control newborns (Oberlander
et al. 2008). This lends support to the hypothesis that DNA
methylation differences in response to social adversity are
system wide and are not limited to brain-specific regions.
Epigenetic modulation of other candidate genes was
implicated in suicide; the gamma-aminobutyric acid A
receptor alpha 1 subunit promoter (Linthorst et al. 1995)
within the frontopolar cortex (Poulter et al. 2008) and
tropomyosin-related kinase B in the frontal cortex of
suicide completers (Ernst et al. 2009). It is unknown yet
whether these changes in DNA are also associated with
early-life adversity.
Genome- and system-wide effects of early-life adversity
Genetics of complex disease has taught us that several
genes must be involved. However, most of our studies were
biased toward the candidate gene approach assuming that
phenotype associated with early-life adversity would
involve a few critical brain-specific genes. In addition,
unsurprisingly the first line of studies examining the impact
of early-life adversity on DNA methylation focused on
specific brain regions. However, it is becoming clear that
genes work in networks and that the total output of a
network could be significantly affected by a combination of
subtle changes in several nodes of a network. The fact that
methylation differences in suicide victims were found in
rRNA genes (McGowan et al. 2008) supports the idea that
genes outside the usual brain-specific suspects are involved.
Also it is clear, by looking at the multiple phenotypes
associated with early-life adversity (Power et al. 2006) that
the response to early-life adversity is not limited to the
brain and that it is a system-wide response.
We recently performed a detailed mapping of five
megabases of DNA spanning the locus of the GR gene
from both directions and identified numerous differences in
DNA methylation between the suicide and the control
groups. Recent high-density epigenome mapping of chro-
mosome 18 in the adult rat offspring of high and low
maternal care reveals broad differences in DNA methyla-
tion and histone acetylation that cover wide regions of
chromosome 18. High maternal care results in hypomethy-
lation of some regions and hypermethylation of others and
an inverse picture is observed with histone acetylation
(McGowan et al. 2011). This can explain why the adult
offspring of high and low LG mother exhibit wide spread
differences in gene expression (Weaver et al. 2006).
We examined association between early-life adversity
and differential DNA methylation in white blood cells. Our
unpublished data indicates associations between DNA
methylation patterns in 45-year-old adults and social
adversity early in life (Borghol et al., unpublished). The
emerging picture supports the hypothesis that early-life
adversity results in modulation of DNA methylation of
many functional gene circuitries resulting in a change in the
total output of these circuitries. This could result in
adaptation to environments later in life or maladaptation.
The fact that DNA methylation changes in blood were
associated with social adversity support the hypothesis that
the response to early-life adversity is system wide and that
it will be possible to follow DNA methylation changes that
are relevant to behavioral pathologies in peripheral blood
cells. However, it is unclear how the specific changes
detected in blood correlate with specific changes in DNA
methylation in the brain.
Signaling pathways as conduits between social
exposures and DNA methylation changes
If indeed these reported changes in DNA methylation are
adaptive mechanisms that respond to social cues there must
be signaling pathways linking social exposure and DNA
methylation and histone acetylation changes. A reasonable
hypothesis is that exposure to social cues results in firing of
a signaling cascade that activates transacting factors that
deliver DNA and chromatin modifying enzymes to specific
regulatory sequences of genes (Fig. 3). Evidence for such a
mechanism comes from the rat maternal care model.
Maternal behavior triggers a signaling pathway that
involves the serotonin receptor, increase in cAMP, recruit-
ment of the transcription factor nerve growth factor-induced
protein A, which in turn recruits the histone acetyltransfer-
ase CREB binding protein (CBP), and the methylated DNA
binding protein and candidate DNA demethylase MBD2
(Weaver et al. 2007) to the GR promoter. Our hypothesis is
244 J Neurodevelop Disord (2011) 3:238–249that the increased histone acetylation triggered by CBP or
by other recruited histone acetyltransferases facilitates the
demethylation of the gene by MBD2 or other DNA
demethylases (Weaver et al., unpublished data). These data
chart a possible conduit through which exposure to a social
behavior such as maternal behavior results in epigenetic
modification of a specific gene in the brain. Although it is
certain that there are other molecular pathways that link
social exposure and changes in DNA methylation in
particular positions in the genome, this example provides
evidence for the feasibility of transducing a social signal
into a DNA methylation mark.
A different signaling cascade linking social exposure
to DNA demethylation provides a mechanism for how
early-life stress results in persistent life-long hypomethy-
lation of the AVP gene. The AVP promoter is methylated
and bound by MECP2. Depolarization of hypothalamic
neurons triggers phosphorylation of MeCp2 at Ser438 by
calcium-dependent calmodulin kinase II (Murgatroyd et
al. 2009). This phosphorylation converts MeCp2 from a
transcriptional silencer with high affinity to methylated
DNA into a transcriptional activator with low affinity to
methylated DNA (Zhou et al. 2006). This facilitates
demethylation of the AVP gene. Phosphorylation of
M e C P 2i nr e s p o n s et on e u r o n a la c t i v a t i o nw a ss h o w n
before to facilitate demethylation of the BDNF promoter
(Chen et al. 2003). This signaling pathway delineates a
direct link between neuronal activation and the phosphor-
ylation state of a protein interacting with methylated genes
in the brain. Neuronal activation resulting in signaling
through phosphorylation of proteins interacting with
methylated DNA might be a general pathway that links
social exposure and the activation of neurons. Future
studies are required to map the signaling pathways that
link early-life adversity to the DNA methylation/deme-
thylation of gene circuitries in brain and T cells. MeCP2 is
especially interesting in autism since deficiencies in
MeCP2 were shown in ASD (Nagarajan et al. 2006). It
will be interesting to map the downstream consequences
of reduced MeCP2 on the methylome in ASD.
PKA
NGFI-A
DNMT
TSA
Methionine
NGFI-A
CH3 CH3 Ac Ac
Early environment
Signaling pathways
CAMKII
demethylase
MeCP2 MeCP2
P
Fig. 3 The early-life environment modulates the DNA methylation
equilibrium; reversibility of DNA methylation. The DNA methylation
equilibrium is laid down during embryogenesis by innate develop-
mental programs. Increased methylation of promoters is associated
with a hypoacetylated and poorly transcribed gene (right)a n d
hypomethylated promoter is hyperacetylated and highly transcribed
(left). A balance of DNA methylation and demethylation activities
dynamically maintains this pattern and is attuned to signals from the
early environment that can modulate the pattern through activation of
signaling pathways that facilitate either increased demethylation or
increased methylation. Two examples were previously reported;
maternal licking and grooming increases serotonin firing increasing
cAMP and activation of protein kinase A, which in turn activates
NGFIA facilitating demethylation and histone acetylation of the GR
exon 17 promoter. Early-life stress triggers activation of CAMKII
kinase resulting in phosphorylation of MeCP2 (P). Phosphorylated
MeCP2 facilitates demethylation and increased transcription of genes
such as AVP. The DNA methylation balance set by early-life
environment could be reversed during adulthood using epigenetic
modifiers such as the histone deacetylase inhibitor TSA or methionine
the precursor of the methyl donor SAM resulting in an epigenetic and
behavioral reversal of the phenotype defined by maternal care. (AC
histone acetylation, CH3 DNA methylation)
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One of the most exciting implications of the epigenetic
mechanism of behavioral disorders is the possibility of
reversing maladaptive DNA methylation marks by either
pharmacological agents (Szyf 1994, 2001)o rs o c i a l
interventions (Szyf 2009b). Our line of reasoning presented
in this review implies that social intervention could
potentially be as effective as pharmacological intervention.
If DNA methylation reaction is reversible as proposed here,
then the DNA methylation pattern could be changed even
in postmitotic tissues in either direction by manipulation of
either DNA methylation/demethylation enzymes or chro-
matin modification enzymes (Fig. 3).
Our previous studies have shown that increasing histone
acetylation using the HDAC inhibitor trichostatin A (TSA)
facilitates replication-independent demethylation of non-
replicating plasmid DNA in human cells (Cervoni and Szyf
2001; Cervoni et al. 2002). This experiment demonstrated
that human somatic cells contain the enzymatic machinery
required to demethylate DNA in the absence of DNA
replication and that it is possible to alter the DNA
methylation pattern using pharmacological agents that
change histone acetylation (Cervoni and Szyf 2001;
Cervoni et al. 2002). We tested whether a similar strategy
would reverse epigenetic states established through mater-
nal care and whether they would result in a change in the
phenotype. Injection of the HDAC inhibitor TSA into the
brains of adult offspring of low LG maternal care reversed
the epigenetic programming of the GR exon 17 promoter
and reestablished stress responsivity and open-field behav-
ior that was indistinguishable from the offspring of high LG
maternal care (Weaver et al. 2004).
We have previously shown that it is possible to alter the
state of methylation of a non-replicating plasmid by treating
cells with the methyl donor SAM which inhibited the DNA
demethylation reaction (Detich et al. 2003.). Injection of the
amino acid methionine, the precursor of SAM, into the
brains of adult offspring of high maternal LG resulted in
increased DNA methylation and downregulation of GR as
well as heightened stress responsivity and an open-field
behavior that was indistinguishable from the adult offspring
of low maternal LG (Weaver et al. 2004, 2005). These data
suggest that both the methylating and demethylating
enzymes are present in the adult neuron and are amenable
to pharmacological modulation. Although the number of
DNA methylation and demethylation inhibitors is limited
and they are extremely nonspecific, such agents have
shown promise in cancer therapy (for review, see (Szyf
2009a)). Development of highly specific inhibitors of
proteins from the DNA methylation machinery might
revolutionize the pharmacological approach to mental
health.
Summary and prospective
Autism demonstrates robust heritability suggesting a strong
genetic component. However, our calculations of genetic
heritability are based to a large extent on monozygotic twin
studies. Monozygotic twins share not only genes but also
environments and a common germ line DNA methylation
pattern(Kaminskyetal.2009). It is therefore possible that the
genetic contribution to autism has been overestimated and
the epigenetic component underestimated. The possibility
that autism has an epigenetic basis that is driven by either
stochastic drifts in DNA methylation, the perinatal environ-
mentortheearly-lifesocialenvironmentmustbeinvestigated.
Several studies point to an epigenetic basis for autism. RETT
syndrome a mental retardation disorder that is similar in
certain aspects with autistic spectrum disorders is caused by a
deficiency in MeCP2 an epigenetic protein that binds
methylated DNA and has several roles in interpretation of
the DNA methylation pattern as well in controlling DNA
methylation states (Amir et al. 1999). Alterations in DNA
methylation in the promoter of MeCP2 were shown in
autistic brains linking autism, DNA methylation and MeCP2
(Nagarajan et al. 2006). An attractive prospect is that an
epigenetic molecular link will be unraveled between certain
early-life social environments and autism.
One difficulty in exploring the epigenetic contribution to
autismisthatcurrentlyitisnotpossibletomonitorinthebrain
of subjects with autism the tissue- and cell-type-specific
changes that can occur in the epigenome. This is not a factor
for de novo orinherited genetic mutations,which are identical
in all cells and therefore can be monitored in any peripheral
cell source. DNA methylation signatures are potential
diagnostics and predictors of autism but if the changes in
DNA methylation are limited to the brain they will have no
diagnostic utility. Obviously, analysis of postmortem autistic
brains will provide valuable information on the mechanisms
involved but will have no diagnostic value. However, as
discussed above there is evidence to suggest that some of the
responses to early-life adversity are not limited to the brain.
Therefore, it is tempting to speculate that it might be possible
to delineate DNA methylation signatures of autism in
peripheral blood cells. Although it is stands to reason that
the DNA methylation signatures in T cells will not inform us
about methylation changes in brain-specific genes, it is
plausible that they will inform us about a systemic component
of the epigenetic processes that contributed to the disorder.
This possibility could only be tested in future studies that
would directly examine whether there is a DNA methylation
signature in T cells or other immune cell type that associates
withautism.IfindeedthereisaDNAmethylationsignatureof
autism, a critical question is whether changes in immune cells
DNA methylation is mechanistically related to the behavioral
effects or whether these changes are parallel consequences of
246 J Neurodevelop Disord (2011) 3:238–249a system wide epigenetic response. Bilateral crosstalk
betweenthe immunesystem and the brain iswelldocumented
but any role in autism is speculative at this stage.
If indeed there is a systemic epigenetic defect that is
associated with the disease, epigenetic intervention through
changes in dietary methyl donor components, epigenetic
drugs, or behavioral interventions might be effective. Periph-
eral DNA methylation marks in immune cells would allow
monitoring of the response of the methylome to the therapy.
We raised in this review the possibility that disorders
such as autism are caused by organized adaptive responses
of the epigenome to early-life environment rather than a
stochastic DNA methylation drift. Understanding the nature
of these responses could provide guidance as to the link
between the early environment and autism and direct
possible preventative strategies.
In difference from genetic polymorphisms that are fixed
and terminal, epigenetic changes are potentially reversible.
One unexplored but nevertheless provocative possibility is
that epigenetic or behavioral interventions that have
epigenetic effects will serve as therapeutic alternatives for
treating and reversing autism. Epigenetic markers might
provide in the future guidance as well for non-
pharmacological interventions. Although the evidence for
the involvement of DNA methylation and autism is still
sparse, the tremendous potential of such a mechanism calls
for an intensive effort to test this hypothesis.
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